These 3 stocks could be big winners in the 4th quarter.
Shares of Global Blood Therapeutics currently are in the bargain bin.
Novo is 'not yet screamingly cheap, but it is certainly approaching great value.'
Things look promising for Rockwell Automation and four other names.
We tend to attach a stigma to losing trades.
Check out the decline in P/E ratios.
Although I don't view the index charts as that bullish, I do like some individual stocks.
GW Pharma could be the answer to an opiate addiction that isn't understood.
Valeant Pharmaceuticals hasn't convinced buyers to return, that's what my charts say.
Shares are finally roaring back from big losses in 2014 and 2015.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.